Thyrocare schedules conference call on May 7, 2026, to discuss audited Q4 and FY26 results.
Management including MD & CEO Rahul Guha and CFO Vikram Gupta will host the investor interaction.
The company revised the webcast link for the call but confirmed no other details have changed.
Disclosure confirms compliance with SEBI LODR Regulation 30 and states no UPSI will be shared.